Search
BioCryst Pharmaceuticals Inc
BCRXAdd to Watchlist
10.730USD
+0.140+1.32%
Close 08-12 16:00（ET）Quotes delayed by 15 min
2.74BMarket Cap
LossP/E TTM
BioCryst Pharmaceuticals Inc's Company Valuation
Currency: USD Updated: 2026-08-12The current valuation score of BioCryst Pharmaceuticals Inc is 8.64, ranking 110 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -6.15, which is -227.97% below the recent high of 7.87 and -2874.47% above the recent low of -182.87.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.